ESR1 and breast cancer: TAM (1 μM) significantly reduced the number of formed tumor spheres by approximately 40% in ER+ breast cancer cells, whereas CSNK1G2 silencing itself did not alter the formation of ER+-MCF-7 tumor spheres (Fig 3A–3C).